Someone with a lot of money to spend has taken a bearish stance on Horizon Therapeutics (NASDAQ:HZNP).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Horizon Therapeutics Plc (NASDAQ:HZNP) confirmed it’s engaged in preliminary talks with Amgen Inc (NASDAQ: AMGN), Janssen Global Service, and Sanofi SA (NASDAQ: SNY) on potential takeover offers for…
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today
-- Month 12 results from MIRROR randomized controlled trial to be featured on Nov. 13, 11:45 a.m. EST during plenary session at the American College of Rheumatology Convergence 2022 --
-- Imaging analyses visualize